Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M192Revenue (TTM) $M47.4Net Margin (%)-55.0Altman Z-Score1.0
Enterprise Value $M156EPS (TTM) $-0.2Operating Margin %-54.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-54.6Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %-1.5Quick Ratio2.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %28.7Current Ratio2.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-39.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)-120.7Gross Margin Increase y-yN

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSFirst Eagle Investment 2012-06-30 Sold Out $2.72 - $3.71
($3.13)
$ 1.24-60%Sold Out0
ATRSFirst Eagle Investment 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 1.24-25%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRAHAM PETER JSVP General Counsel, Secretary 2016-03-21Buy20,000$0.7764.94view
APPLE ROBERT FPresident & CEO 2016-03-18Buy60,000$0.7276.39view
GUETH ANTONDirector 2016-03-18Buy50,000$0.7276.39view
Fickenscher James ESenior Vice President & CFO 2016-03-18Buy135,000$0.7276.39view
JACOB LEONARD SDirector 2016-03-18Buy50,000$0.7276.39view
GONELLA JACQUESDirector 2016-03-18Buy100,000$0.7276.39view
GARRITY THOMAS JDirector 2016-03-18Buy30,000$0.7276.39view
SAMSON MARVINDirector 2016-03-18Buy50,000$0.7276.39view
ROCHE ROBERT P JRDirector 2016-03-18Buy50,000$0.7276.39view
Flynn James E 2015-09-30Sell1,828,529$1.79-29.05view

Quarterly/Annual Reports about ATRS:

News about ATRS:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

More From Other Websites
ETF’s with exposure to Antares Pharma, Inc. : August 30, 2016 Aug 30 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and... Aug 30 2016
Antares Pharma Reports Second Quarter 2016 Operating And Financial Results READ Aug 30 2016
Have You Heard About This Generic EpiPen Maker? Aug 24 2016
ANTARES PHARMA, INC. Financials Aug 19 2016
ETF’s with exposure to Antares Pharma, Inc. : August 16, 2016 Aug 16 2016
Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 Aug 15 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 11 2016
Antares Pharma reports 2Q loss Aug 09 2016
Antares Pharma reports 2Q loss Aug 09 2016
Q2 2016 Antares Pharma Inc Earnings Release - Before Market Open Aug 09 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 09 2016
Antares Pharma Reports Second Quarter 2016 Operating and Financial Results Aug 09 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and... Aug 02 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and... Aug 02 2016
ETF’s with exposure to Antares Pharma, Inc. : July 26, 2016 Jul 26 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 01 2016
Antares Pharma (ATRS) in Focus: Stock Moves 10.2% Higher Jun 28 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States Jun 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)